BioWorld MedTech

Oct. 19, 2011

InfraReDx reports new data for LipiScan imaging system

Of all the tools doctors have in their belt to help patients with, those which help them make a more accurate diagnosis tend to be the most valuable. Read More

NeuroQuant could help in early detection of dementia

Foundation closes expanded round, brings total to $33.5M

AMIC says pre-authorization will not save Medicare dollars

Capsule reports plans to expand connectivity offering in Europe

MDD's food for med-tech thought

CapitalCare to use EHR software training platform

Flamel to produce GSK's Coreg CR microparticles

Product Briefs

Blaze Bioscience enters into license deal with FHCRC

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 9, 2025.

Prokidney produces positive phase II CKD data, thunderous stock surge

BioWorld

A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....

In a $10B deal, Merck buys cardio developer Verona

BioWorld

In the second largest M&A deal of the year, Merck & Co. Inc. has strengthened its cardiopulmonary portfolio with the $10 billion acquisition of London-based...

Illustration of the β2-adrenergic receptor

Exercise-mimicking compound offers alternative to GLP-1 therapies

BioWorld

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...